Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors

In this real-world study, baricitinib provided substantial long-term effectiveness with a favorable safety profile in moderate-to-severe AD, and atopic comorbidities emerged as a predictor of optimal clinical response at week 16.

Authors

Institutions

Publication Details

Journal
Journal of Dermatological Treatment
Published
2025-11-03
DOI
https://doi.org/10.1080/09546634.2025.2578249
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors

Luca Bianchi, Maddalena Napolitano, Maria Esposito, Eugenia Veronica Di Brizzi et al.
Journal of Dermatological Treatment
Dermatology and Skin Diseases
article

Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors

Luca Bianchi, Maddalena Napolitano, Maria Esposito, Eugenia Veronica Di Brizzi, Niccolò Gori, Lina Maria Magnanimi, Claudia Paganini, Maddalena Nicoletti, Lucia Di Nardo, Marina Talamonti, Marco Galluzzo, Anna Balato, Maria Concetta Fargnoli, Andrea De Berardinis, Cataldo Patruno, Flaminia Antonelli, Giuseppe Lauletta, Ketty Peris, Francesca di Vico, Elena Ippoliti, Luisa Boeti
article en

Abstract

In this real-world study, baricitinib provided substantial long-term effectiveness with a favorable safety profile in moderate-to-severe AD, and atopic comorbidities emerged as a predictor of optimal clinical response at week 16.

Journal of Dermatological TreatmentVol. 36(1)
Università Cattolica del Sacro Cuore (IT), University of Rome Tor Vergata (IT), University of Molise (IT), University of Campania "Luigi Vanvitelli" (IT), University of L'Aquila (IT), Agostino Gemelli University Polyclinic (IT), San Salvatore Hospital (IT), University of Campania "Luigi Vanvitelli" (IT), Policlinico Tor Vergata (IT), University of Naples Federico II (IT)
Openalex Percentile: Top 47%
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.